Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Mar 19, 2009


GE Healthcare this week announced Pascale Witz has been appointed president and CEO of GE Healthcare, Medical Diagnostics.

Witz has been in charge of the company's Healthcare Systems Interventional global business, which researches and develops medical diagnostic technologies.

Doug White joined BG Medicine earlier this month as executive vice president and general manager for the company's diagnostics operations.

In the newly created role, White is responsible for the strategic direction and overall management of the company's commercial operations "as it advances a broad portfolio of high-value diagnostic tests toward commercial launch," BG Medicine said in a statement.

White has 24 years of experience in the in vitro diagnostic marketplace. Before joining BG Medicine, he was senior VP of sales and marketing for the Americas and chair of the Americas Management Council at Qiagen. He was also senior VP of commercial operations at Digene before that company was acquired by Qiagen.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.